Drugs / Sivopixant
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT06776432 Comparator | Apr 2025 → Dec 2026 expected | sleep apnea syndrome | Shionogi | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sivopixant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06776432 ↗ |
| Route | Oral | “Participants will receive sivopixant oral tablets once daily at bedtime for 17 days.” NCT06776432 ↗ |